AIM ImmunoTech Inc. financial data

Symbol
AIMI on OTC
Location
2117 Sw Highway 484, Ocala, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 38.6 % -79%
Debt-to-equity -470 %
Return On Equity 734 %
Return On Assets -199 % -40.1%
Operating Margin -13.7K % +12.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.71M shares -95.3%
Common Stock, Shares, Outstanding 764K shares -98.7%
Entity Public Float 20.8M USD -34.7%
Common Stock, Value, Issued 1K USD -98.2%
Weighted Average Number of Shares Outstanding, Basic 759K shares +43.7%
Weighted Average Number of Shares Outstanding, Diluted 759K shares +43.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 121K USD -39.8%
Revenue from Contract with Customer, Excluding Assessed Tax 121K USD -39.8%
Research and Development Expense 5.36M USD -40.7%
General and Administrative Expense 11.3M USD -50%
Costs and Expenses 16.7M USD -47.4%
Operating Income (Loss) -16.6M USD +47.4%
Net Income (Loss) Attributable to Parent -16.2M USD +42.4%
Earnings Per Share, Basic 0 USD/shares +74%
Earnings Per Share, Diluted 0 USD/shares +74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 476K USD -86.6%
Marketable Securities, Current 359K USD -94.5%
Accounts Receivable, after Allowance for Credit Loss, Current 1.18M USD -29.4%
Assets, Current 1.03M USD -90.1%
Property, Plant and Equipment, Net 89K USD -18.3%
Operating Lease, Right-of-Use Asset 496K USD -29.1%
Other Assets, Noncurrent 351K USD -82.9%
Assets 4.13M USD -73.7%
Accounts Payable, Current 7.3M USD +33.8%
Employee-related Liabilities, Current 1K USD -99.8%
Accrued Liabilities, Current 573K USD -28.3%
Liabilities, Current 10.4M USD +17.5%
Operating Lease, Liability, Noncurrent 282K USD -42.2%
Liabilities 10.7M USD +11%
Retained Earnings (Accumulated Deficit) -433M USD -3.88%
Stockholders' Equity Attributable to Parent -6.55M USD -207%
Liabilities and Equity 4.13M USD -73.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.36M USD +51%
Net Cash Provided by (Used in) Financing Activities 660K USD -76.7%
Net Cash Provided by (Used in) Investing Activities 898K USD
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 764K shares -98.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -803K USD +62.5%
Deferred Tax Assets, Valuation Allowance 42.9M USD +16.5%
Deferred Tax Assets, Gross 42.9M USD +11.6%
Operating Lease, Liability 515K USD -28.7%
Depreciation 10K USD +11.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.3M USD +40.2%
Property, Plant and Equipment, Gross 1.47M USD -5.72%
Operating Lease, Liability, Current 233K USD -0.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 159K USD -34.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 254K USD -6.96%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 40K USD -62.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 159K USD -20.5%
Deferred Tax Assets, Operating Loss Carryforwards 29M USD +15.5%
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 133K USD -33.5%
Additional Paid in Capital 427M USD +0.85%
Amortization of Intangible Assets 48K USD -2.04%
Share-based Payment Arrangement, Expense 0 USD -100%
Interest Expense 607K USD -16.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%